At a glance
ClinicalIndex Comparison RecordN/ACompleted· 20 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
To Evaluate the Clinical Utility of Specific Autoantibody Testing in Patients With Interstitial Lung Disease
In Brief
An observational study for Interstitial Lung Disease. Completed, enrolled 20 participants across 1 site.
Detailed Summary
The purpose of this study is to evaluate the clinical utility of specific autoantibody testing in unmasking an underlying connective tissue disorder in patients who present with interstitial lung disease and found to have weak positive ANA (1:400 titre) with no overt connective tissue disease manifestations OR borderline/negative ANA with some clinical suggestion of connective tissue disease.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsInterstitial Lung Disease
CountriesSingapore
Collaborators--
Timeline
N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
Enrollment StartMay 2012
First PostedMay 2012
Primary CompletionApr 2017
TodayJul 2026
First PostedMay 17, 2012
Enrollment StartMay 1, 2012
Primary CompletionApr 1, 2017
TodayJul 2, 2026
Enrollment to primary: 4.9 yearsPosted 14.1 years ago